Other Mammals adverse-event record

Other Mammals Adverse Event Insights

The FDA Center for Veterinary Medicine database holds 39 adverse event reports for Other Mammals, distributed across 0 distinct breeds currently tracked in the system. Of those reports, 7 involved a death outcome, producing a 17.9% case-fatality rate among reported events, which reflects reporting severity bias rather than true population mortality. These figures are aggregated directly from openFDA's Animal & Veterinary Adverse Events endpoint and update as new voluntary submissions flow through pet owners, veterinarians, and drug manufacturers.

The most frequently reported clinical signs for Other Mammals are INEFFECTIVE, SEDATION (11 reports), INEFFECTIVE, ANESTHESIA (7 reports), Lack of efficacy - NOS (6 reports), Death (5 reports), with INEFFECTIVE, SEDATION leading the reaction traffic at 11 submissions. On the product side, Dexmedetomidine Hydrochloride is the single most-referenced drug with 12 reports, followed by Ketamine Hydrochloride (5), Ketamine (2), Altrenogest Oily Solution (2). This combination surfaces which therapeutic classes generate the most adverse event chatter for this species, a useful starting point when comparing Other Mammals reporting patterns against other companion animals in the dataset.

Of the 40 Other Mammals reports with a coded outcome, Outcome Unknown accounts for the largest share at 57.5%. Annual submission volume spans 1 to 12 reports across the 11 years on file, a range that reflects evolving owner awareness, veterinary reporting habits, and new product approvals rather than stable underlying incidence. The breed-level table below breaks these patterns down further, showing how the 0 tracked other mammals breeds compare on volume, deaths, and average age at report. As with all FDA adverse event data, correlation is the ceiling, causation requires clinical investigation beyond what these aggregates can provide.